Rhythm Pharmaceuticals' GAAP loss for 3 months of 2022 was $52.764 million, compared to a profit of $43.75 million in the previous year. Revenue increased 42.8 times to $1.498 million from $0.035 million a year earlier.
Rhythm Pharmaceuticals' GAAP loss for 3 months of 2022 was $52.764 million, compared to a profit of $43.75 million in the previous year. Revenue increased 42.8 times to $1.498 million from $0.035 million a year earlier. 
ir.rhythmtx.com
English (US) 